Please check your internet connection and try again.
## Miconazole Vaginal Pessary
### Overview
Miconazole is an imidazole antifungal agent used to treat vaginal candidiasis (yeast infections). It is available in various vaginal formulations, including pessaries.
### Primary Indications
* Treatment of vulvovaginal candidiasis.
### Adult Dosing
* **100 mg vaginal pessary:** Insert 1 pessary vaginally at bedtime for 7 consecutive days.
* **200 mg vaginal pessary:** Insert 1 pessary vaginally at bedtime for 3 consecutive days.
* **Combination packs (e.g., 1200 mg single-dose pessary):** Insert 1 pessary vaginally as a single dose.
The optimal duration of therapy may vary based on the severity of infection and individual patient response.
### Pediatric Dosing
* **Children 12 years and older:** Use adult dosing.
* **Children younger than 12 years:** Safety and efficacy have not been established. Consult with a pediatrician for appropriate management.
### Dose Adjustments
No dose adjustments are typically required for renal or hepatic impairment when used as a vaginal pessary due to minimal systemic absorption.
### Contraindications
* Hypersensitivity to miconazole or any component of the formulation.
### Adverse Effects
* **Common:** Vaginal burning, itching, irritation, and vulvar edema.
* **Less Common:** Pelvic cramps, headache.
### Key Drug Interactions
* **Warfarin:** Miconazole (particularly oral formulations, but caution with vaginal products) can inhibit CYP2C9, potentially increasing warfarin levels and INR. Monitor INR closely if co-administered.
* **CYP3A4 substrates:** Miconazole can inhibit CYP3A4. While systemic absorption is minimal with vaginal use, caution is advised with drugs that have a narrow therapeutic index and are primarily metabolized by CYP3A4.
### Monitoring
* Clinical signs and symptoms of vaginal candidiasis (e.g., pruritus, erythema, discharge).
* Monitor for signs of local irritation or hypersensitivity.
### Clinical Pearls
* Ensure complete insertion of the pessary for optimal drug delivery.
* Avoid sexual intercourse during treatment to prevent potential irritation and to ensure efficacy.
* Inform patients that treatment may need to be repeated if symptoms persist or recur.
* For recurrent or complicated infections, further diagnostic evaluation may be warranted.
***
*Disclaimer: This information is intended for healthcare professionals. It is essential to consult the most current prescribing information and relevant clinical guidelines before making any treatment decisions. Dosing and recommendations may vary based on specific product labeling, patient factors, and local protocols.*
